DID YOU FILE A CLAIM AGAINST PURDUE PHARMA AS PART OF ITS BANKRUPTCY PROCEEDING? DO YOU HAVE A CLAIM AGAINST PURDUE PHARMA’S OWNERS?

A Hearing to Consider Confirmation of the Chapter 11 Plan May Affect Your Rights.

WHAT IS THIS ABOUT?

On June 3, 2021, as part of Purdue Pharma L.P.’s bankruptcy proceedings, the United States Bankruptcy Court for the Southern District of New York entered an order called the “Disclosure Statement Order” that:

(a) Authori ed Purdue Pharma L.P. and its a liated debtors and debtors in possession to solicit acceptances of the Fifth Amended Joint Chapter 11 Plan of Reorganization of Purdue Pharma

P and tA li ate de tor, which includes( a) releases of any actual or potential claims against Sackler family members, and certain other individuals and related entities, relating to Purdue Pharma L.P. and its a liated debtors (including Purdue prescription opioids, like OxyContin, or other prescription opioids manufactured or sold by Purdue); and (b) an injunction requiring that certain claims against the released parties be asserted only against trusts established under the plan;

(b) Approved the i lo ure tatement for Fifth Amended Joint Chapter 11 Plan for P ur due P harm a PandtA li ate de tor as containing “adequate information” pursuant to section 1125 of the Bankruptcy Code;

(c) Approved the solicitation materials and documents to be included in solicitation packages; and

(d) Approved procedures for soliciting, receiving, and tabulating votes on the plan and for ling objections to the plan.

The Court will consider con rmation of the plan at the Con rmation earing.

WHEN IS THE HEARING?

The Con rmation earing will be held on August 9, 2021, at

10 a.m., prevailing Eastern Time, before the onorable Robert D. Drain, in the United States Bankruptcy Court for the Southern District of New York, located at 300 Quarropas Street, White Plains, New York 10601-4140. The hearing will be conducted via Zoom videoconference for those who will be participating in the Con rmation earing1 if General Order M-543 is still in effect or unless otherwise ordered by the Bankruptcy Court.

The Con rmation earing may be extended and rescheduled by the Court or the Debtors without further notice by an agenda led with the Court, and or by a Notice of Adjournment

led with the Court and delivered to all parties who are entitled to notice.

WHAT ARE YOUR OPTIONS?

Vote on the Plan: Your vote must be submitted so it is actually received on or before July 14, 2021, at 4:00 p.m., prevailing Eastern Time. Detailed instructions on how to vote are available

at PurduePharmaClaims.com or by calling (844) 217-0912 (toll free) or (347) 859-8093 (international). Failure to follow instructions properly may disqualify your vote.

Object to the Plan: An objection must be submitted so that it is actually received on or before July 19, 2021, at 4:00 p.m., prevailing Eastern Time. Detailed instructions on how to

le an objection are available at PurduePharmaClaims.com or by calling (844) 217-0912 (toll free) or (347) 859-8093 (international).

Allowance Request: If you believe that you hold a claim against Purdue Pharma L.P. that is not currently entitled to vote but that you believe should be entitled to vote, you can request the allowance of such claim for voting purposes. To do so, you must le a motion with the Court on or before July 19, 2021, at 4:00 p.m., prevailing Eastern Time. Detailed instructions on how to le an allowance request are available at PurduePharmaClaims.com or by calling (844) 217-0912 (toll free) or (347) 859-8093 (international).

If the plan is con rmed, anyone with an actual or potential claim against Purdue Pharma L.P. or any of its a liated debtors, or with an actual or potential claim against Sackler family members, and certain other individuals and related entities, relating to Purdue Pharma L.P. and its a liated debtors (including Purdue prescription opioids, like OxyContin, or other prescription opioids manufactured or sold by Purdue), will be bound by the terms of the plan, including the releases and injunctions contained therein.